Dr. Martens’ UK revenue fell 21.3 per cent at constant currency in the first half of its financial year, as hot summer weather hit demand for its boots.
In results for the half year to 27 September 2026, published on 12 November, the footwear brand reported group revenue down 9.8 per cent to £290.4m, or 9.2 per cent at constant currency.
Key figures
- Direct-to-consumer (retail and eCommerce) revenue down 12.8 per cent at constant currency to £156.6m, or 53.6 per cent of group revenue.
- Wholesale (B2B) revenue down 4.7 per cent at constant currency to £135.8m.
- Pairs sold down 10.5 per cent to 4.2 million.
- Gross margin steady at 65.3 per cent.
- Adjusted loss before tax of £13.7m, against a £9.4m loss a year earlier.
- Interim dividend held at 0.85p.
Dr. Martens said UK performance was below its plans, reflecting a challenging market and weak results in both DTC and boots. US revenue fell 5.1 per cent at constant currency.
The company said October group revenue improved on a very weak September but remained in line with the second-quarter run rate of a mid-teens percentage decline. DTC remained challenging, with the October decline still driven by boots.
Chief executive Ije Nwokorie described the first half as disappointing. The company said November, December and early January, including Black Friday weekend and the post-Christmas sale, are crucial to its full-year result, and that there is a wide range of possible outcomes for revenue and profit.
Share